Each time I engage with global health research I am reminded of how many studies never reach the […]
LLM advice for the publicMuch is made of how large language models (LLMs) can pass medical licensing exams […]
People taking glucagon-like peptide-1 (GLP-1) receptor agonists often describe a quieting of “food noise”—persistent thoughts about food and […]
A woman in her 20s presented with a three month history of persistent erythematous patches on both thighs. […]
AbstractObjectivesTo investigate whether initiation of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with both reduced risks of incident […]
Scientists have uncovered a crucial weakness in the malaria parasite that could open the door to new treatments. […]
Substance use disorders (SUDs) are common and burdensome for patients, families, and health systems,12 yet effective albeit underused […]
Updated Date: Tue, 24 Feb 2026 00:00:00 EST
First‑in‑human phase 1/2a study launches in China and the US targeting advanced cancers
New funding will support the phase 2 expansion trial of THEO-260